| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |